Annual CFF
$78.97 M
+$58.17 M+279.77%
December 31, 2021
Summary
- As of February 10, 2025, PLXP annual cash flow from financing activities is $78.97 million, with the most recent change of +$58.17 million (+279.77%) on December 31, 2021.
- During the last 3 years, PLXP annual CFF has risen by +$78.97 million (+100.00%).
Performance
PLXP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$1.09 M
-$244.00 K-18.35%
September 30, 2022
Summary
- As of February 10, 2025, PLXP quarterly cash flow from financing activities is $1.09 million, with the most recent change of -$244.00 thousand (-18.35%) on September 30, 2022.
- Over the past year, PLXP quarterly CFF has dropped by -$10.25 million (-90.42%).
Performance
PLXP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$2.61 M
-$10.25 M-79.67%
September 30, 2022
Summary
- As of February 10, 2025, PLXP TTM cash flow from financing activities is $2.61 million, with the most recent change of -$10.25 million (-79.67%) on September 30, 2022.
- Over the past year, PLXP TTM CFF has dropped by -$92.04 million (-97.24%).
Performance
PLXP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PLXP Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +279.8% | -90.4% | -97.2% |
| 3 y3 years | +100.0% | +100.5% | -79.3% |
| 5 y5 years | +199.0% | -84.8% | -79.3% |
PLXP Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -18.3% | -100.0% | -96.7% | at low |
| 5 y | 5-year | at high | -84.0% | -98.4% | -187.1% | -97.2% | -163.0% |
| alltime | all time | at high | -100.0% | -98.4% | -187.1% | -97.2% | -163.0% |
PLx Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $1.09 M(-18.3%) | $2.61 M(-79.7%) |
| Jun 2022 | - | $1.33 M(>+9900.0%) | $12.86 M(+1.2%) |
| Mar 2022 | - | $0.00(-100.0%) | $12.71 M(-83.9%) |
| Dec 2021 | $78.97 M(+279.8%) | $198.00 K(-98.3%) | $78.97 M(-16.6%) |
| Sep 2021 | - | $11.33 M(+862.1%) | $94.65 M(+14.9%) |
| Jun 2021 | - | $1.18 M(-98.2%) | $82.37 M(-6.4%) |
| Mar 2021 | - | $66.26 M(+317.2%) | $87.99 M(+323.2%) |
| Dec 2020 | $20.79 M(+64.5%) | $15.88 M(-1779.6%) | $20.79 M(+402.8%) |
| Sep 2020 | - | -$945.60 K(-113.9%) | $4.14 M(-26.5%) |
| Jun 2020 | - | $6.79 M(-824.7%) | $5.62 M(-441.5%) |
| Mar 2020 | - | -$937.50 K(+20.9%) | -$1.65 M(-113.0%) |
| Dec 2019 | $12.64 M(>+9900.0%) | -$775.70 K(-243.2%) | $12.64 M(-5.8%) |
| Sep 2019 | - | $541.60 K(-214.1%) | $13.42 M(+4.2%) |
| Jun 2019 | - | -$474.60 K(-103.6%) | $12.87 M(-3.6%) |
| Mar 2019 | - | $13.35 M(>+9900.0%) | $13.35 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2018 | - | $0.00(0.0%) | $7.15 M(-70.0%) |
| Mar 2018 | - | $0.00(0.0%) | $23.84 M(-9.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $26.41 M(+1385.8%) | $0.00(-100.0%) | $26.41 M(-1.0%) |
| Sep 2017 | - | $7.15 M(-57.2%) | $26.69 M(+36.0%) |
| Jun 2017 | - | $16.70 M(+550.2%) | $19.62 M(+351.4%) |
| Mar 2017 | - | $2.57 M(+833.9%) | $4.35 M(+144.5%) |
| Dec 2016 | $1.78 M(-91.0%) | $275.00 K(+266.7%) | $1.78 M(+18.3%) |
| Sep 2016 | - | $75.00 K(-94.7%) | $1.50 M(+15.5%) |
| Jun 2016 | - | $1.43 M(>+9900.0%) | $1.30 M(-93.4%) |
| Dec 2015 | $19.74 M(-42.7%) | $0.00(-100.0%) | $19.74 M(0.0%) |
| Sep 2015 | - | -$126.80 K(-100.6%) | $19.74 M(-0.6%) |
| Jun 2015 | - | $19.87 M(>+9900.0%) | $19.87 M(-42.3%) |
| Dec 2014 | $34.46 M(+649.3%) | $0.00(0.0%) | $34.46 M(-2.6%) |
| Sep 2014 | - | $0.00(0.0%) | $35.39 M(-3.9%) |
| Jun 2014 | - | $0.00(-100.0%) | $36.81 M(-3.5%) |
| Mar 2014 | - | $34.46 M(+3576.1%) | $38.16 M(+729.9%) |
| Dec 2013 | $4.60 M(+132.0%) | $937.30 K(-33.9%) | $4.60 M(+25.6%) |
| Sep 2013 | - | $1.42 M(+5.1%) | $3.66 M(+63.3%) |
| Jun 2013 | - | $1.35 M(+51.3%) | $2.24 M(+151.3%) |
| Mar 2013 | - | $892.50 K | $892.50 K |
| Dec 2012 | $1.98 M | - | - |
FAQ
- What is PLx Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for PLx Pharma?
- What is PLx Pharma annual CFF year-on-year change?
- What is PLx Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for PLx Pharma?
- What is PLx Pharma quarterly CFF year-on-year change?
- What is PLx Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for PLx Pharma?
- What is PLx Pharma TTM CFF year-on-year change?
What is PLx Pharma annual cash flow from financing activities?
The current annual CFF of PLXP is $78.97 M
What is the all time high annual CFF for PLx Pharma?
PLx Pharma all-time high annual cash flow from financing activities is $78.97 M
What is PLx Pharma annual CFF year-on-year change?
Over the past year, PLXP annual cash flow from financing activities has changed by +$58.17 M (+279.77%)
What is PLx Pharma quarterly cash flow from financing activities?
The current quarterly CFF of PLXP is $1.09 M
What is the all time high quarterly CFF for PLx Pharma?
PLx Pharma all-time high quarterly cash flow from financing activities is $66.26 M
What is PLx Pharma quarterly CFF year-on-year change?
Over the past year, PLXP quarterly cash flow from financing activities has changed by -$10.25 M (-90.42%)
What is PLx Pharma TTM cash flow from financing activities?
The current TTM CFF of PLXP is $2.61 M
What is the all time high TTM CFF for PLx Pharma?
PLx Pharma all-time high TTM cash flow from financing activities is $94.65 M
What is PLx Pharma TTM CFF year-on-year change?
Over the past year, PLXP TTM cash flow from financing activities has changed by -$92.04 M (-97.24%)